Tumor‐suppressive actions of let‐7 are attributed to its role in suppressing oncogenes and genes involved in maintenance of pluripotency, such as HMGA2 and LIN28A [49], and let‐7 directly targets these genes in ovarian cancer [31]. This evidence concerns the gene HMGA2 and ovarian cancer.